Shore Quality Partners Teams with Genomind to Help Prevent Adverse Prescription Drug Events
Integrated precision medication management platform empowers clinicians with genetic insights intended to reduce polypharmacy errors that cost thousands of lives and billions of dollars annually.
Genomind Completes Integration with Epic with support from Parkview Physicians Group
Parkview providers now able to order Genomind testing and view results within their Epic EHR system.
Harmony United Psychiatric Care Enhances Behavioral Health Services with Genomind’s Precision Digital Mental Health Platform
Leading behavioral health practice Harmony United Psychiatric Care has integrated Genomind’s pharmacogenomic testing and services into Mendent EMR system.
Major Advancement in Support for Mental Health Patients as Medicare Provides Coverage of the Genomind Professional PGx Express Test and the VA Extends FSS Contract to Help Soldiers and Veterans
The Genomind pharmacogenetic test will be covered and reimbursed by Medicare. The VA has also elected to extend the current FSS contract for Genomind PGx.
Genomind Coordinates With Multiple Health Plans to Expand Access to Its Pharmacogenetics Tools and Help Reduce Mental Health-Related ER and Hospital Visits During the COVID-19 Crisis
Genomind Coordinates With Multiple Health Plans to Expand Access to Its Pharmacogenetics Tools and Help Reduce Mental Health-Related ER and Hospital Visits During the COVID-19 Crisis
Genomind Substantially Increases Customer Access to Pharmacogenetic Mental Health Testing Through Expanded Partnership With Jewel-Osco
To help address the burgeoning mental health crisis in the U.S., specially trained Jewel-Osco pharmacists will play a pivotal role in expanding access to innovative mental health resources. This latest agreement quadruples number of pharmacies in Albertsons Companies offering Genomind’s tests and services.
Genomind Expands Collaboration to Provide Access to Genetics-Based Mental Health Test to Customers in All Pennsylvania ACME Markets
Partnering ACME pharmacists will identify and work with patients who may benefit from genetic testing service aimed at improving mental health treatments.
Genomind Joins Forces With Sharecare to Improve Mental Health Outcomes
Genomind brings expertise in mental health education and pharmacogenomics services to Sharecare’s comprehensive digital health platform.
Genomind Bolsters Medicare Reimbursement Initiatives, Obtaining Z-Codes for Genomind Professional PGx Express
Genomind announced the assignment of a Z-code for its mental health pharmacogenomic (PGx) testing.
Genomind Supports New Reimbursement Initiatives and Patient Access to Mental Health Pharmacogenomic Tests with PGx Report Focused on Anxiety and Depression
New CORE Depression and Anxiety Report follows UnitedHealthcare’s positive coverage decision for Genomind Professional PGx Express for certain patients.
Genomind and DrChrono Expand Collaboration to Improve Mental Health Outcomes With Innovative Technology and Services
Genomind and DrChrono Expand Collaboration to Improve Mental Health Outcomes With Innovative Technology and Services.
Genomind® Completes $11 Million Financing to Fund Business Expansion
Genomind has completed an $11 million financing with its existing shareholders and Silicon Valley Bank (SVB) to further fuel Genomind’s expansion.
Genetic Testing for Mental Health Approved as New Ally for Military Personnel and Veterans
Veterans and active military personnel are now eligible to receive the Genecept Assay®, a genetic test for mental health that helps patients feel better.
Genomind Secures Latest Round of Financing that Will Solidify Strategic Plan for Company’s Growth
Genomind Secures Latest Round of Financing that Will Solidify Strategic Plan for Company’s Growth
Genomind Secures Series A Investment Led By Claritas Capital To Fund Growth Of Their Personalized Medicine Company
Genomind Secures Series A Investment Led By Claritas Capital To Fund Growth Of Their Personalized Medicine Company
